Literature DB >> 1234044

The association of H-2 antigens and EAC receptors on the surface of peritoneal cells.

M Schlesinger, M Chaouat.   

Abstract

The exposure of murine peritoneal cells to anti-H-2 sera results in a diminished expression of H-2 antigen on the cell surface. Concomitant with this "H-2 modulation" the capacity of macrophages to bind sheep red blood cells coated with antibody and complement (EAC) was markedly diminished. In contrast, there was no change in the capacity of modulated macrophages to bind sheep red blood cells coated with antibody alone (EA). Antibodies to K end H-2 specificities were more effective in reducing the binding of EAC than antibodies to D end H-2 specificities. Exposure of peritoneal cells to O or Ly antisera had no effect on the formation of EAC rosettes. Exposure of peritoneal cells to anti-H-2 sera, under conditions which would not allow modulation of H-2 antigens, also prevented the reduction of EAC binding. Thus, the EAC receptors and H-2 antigenic specificities seem to be closely related on the surface of peritoneal cells, but constitute distinct cell surface structures. Preliminary evidence indicates that vinblastine, a microtubule depolymerizing agent, may disrupt the close association of EAC receptors and H-2 antigens. It is suggested that the association of EAC receptors and K end H-2 determinants on the membrane of macrophages may have implications for the regulation of the immune response by H-2-linked Ir genes.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1234044     DOI: 10.1002/eji.1830050107

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  2 in total

1.  Antigenic properties of subsets of splenic T lymphocytes responding to lectins.

Authors:  M Schlesinger; E Israel; I Gery
Journal:  Immunology       Date:  1976-06       Impact factor: 7.397

Review 2.  Mechanisms of macrophage activation.

Authors:  H M Ogmundsdóttir; D M Weir
Journal:  Clin Exp Immunol       Date:  1980-05       Impact factor: 4.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.